Anaplastic Large Cell Lymphoma

Anaplastic Large Cell Lymphoma

About Anaplastic Large Cell Lymphoma

Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of peripheral T-cell lymphoma (PTCL). ALCL makes up about 2% of lymphomas and approximately 24% of all PTCL in the US.

A diagnosis of ALCL requires taking a biopsy (sample of the tumor tissue) and looking at the cells under a microscope. Additional tests may be conducted to give physicians more information about the disease and how far it has spread in the body. These can include:

  • Blood tests
  • Computed tomography (CT) scan (a procedure that uses x-rays to make detailed pictures of the inside of the body)
  • Positron emission tomography (PET) scan (a procedure that uses a special dye to locate the cancer in the body)
  • Magnetic resonance imaging (MRI) scan (a procedure that uses a powerful magnet and radio waves to take detailed pictures of the inside of the body)
  • Bone marrow biopsy (a procedure that uses a needle to take samples of the spongy tissue inside the bones).

One characteristic that distinguishes ALCL is that the cancer cells have a marker on their surface called CD30. The disease can present in different forms, which are treated differently:

  • Primary cutaneous ALCL: disease is limited to the skin.
  • Systemic ALCL: disease that can affect lymph nodes and other organs, including the skin.
  • Breast implant-associated (BIA) ALCL: disease is present around breast implants.

Patients with systemic ALCL are divided into two groups, depending on whether their cells produce an abnormal form of a protein called anaplastic lymphoma kinase (ALK):

  • ALK-positive ALCL (cancer cells produce ALK) is more common in children and young adults.
  • ALK-negative ALCL (cancer cells do not produce ALK) is more common in older adults (over 54 years old).

Learn More

To learn more about ALCL, view the T-Cell Lymphomas Guide. Want to talk to someone? For answers to lymphoma-related questions 
and resources, contact our Lymphoma Resource Center at (800) 500-9976 or [email protected].

Additional Resources

To learn more about ALCL, view the T-Cell Lymphomas Guide.

Events